546 related articles for article (PubMed ID: 22235050)
1. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
[TBL] [Abstract][Full Text] [Related]
2. The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.
Lakota K; Perdan-Pirkmajer K; Sodin-Šemrl S; Čučnik S; Šubelj V; Prosenc K; Mrak Poljšak K; Tomšič M; Ambrožič A; Praprotnik S
Clin Rheumatol; 2019 May; 38(5):1277-1292. PubMed ID: 30761436
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults.
Toplak N; Kveder T; Trampus-Bakija A; Subelj V; Cucnik S; Avcin T
Autoimmun Rev; 2008 Dec; 8(2):134-8. PubMed ID: 18700173
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases.
Saad CG; Borba EF; Aikawa NE; Silva CA; Pereira RM; Calich AL; Moraes JC; Ribeiro AC; Viana VS; Pasoto SG; Carvalho JF; França IL; Guedes LK; Shinjo SK; Sampaio-Barros PD; Caleiro MT; Goncalves CR; Fuller R; Levy-Neto M; Timenetsky Mdo C; Precioso AR; Bonfa E
Ann Rheum Dis; 2011 Jun; 70(6):1068-73. PubMed ID: 21540203
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
Urowitz MB; Anton A; Ibanez D; Gladman DD
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases.
Elkayam O; Amir S; Mendelson E; Schwaber M; Grotto I; Wollman J; Arad U; Brill A; Paran D; Levartovsky D; Wigler I; Caspi D; Mandelboim M
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1062-7. PubMed ID: 21425247
[TBL] [Abstract][Full Text] [Related]
8. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
[TBL] [Abstract][Full Text] [Related]
9. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.
Touma Z; Gladman DD; Urowitz MB
Curr Opin Rheumatol; 2013 Mar; 25(2):164-70. PubMed ID: 23370371
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.
Lertdumrongluk P; Changsirikulchai S; Limkunakul C; Prachukthum P; Punpiput P; Buppanharun R; Chotpitayasunondh C
Vaccine; 2012 Feb; 30(6):1108-14. PubMed ID: 22178515
[TBL] [Abstract][Full Text] [Related]
11. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
12. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
[TBL] [Abstract][Full Text] [Related]
13. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
Schuurmans MM; Tini GM; Dalar L; Fretz G; Benden C; Boehler A
J Heart Lung Transplant; 2011 Jun; 30(6):685-90. PubMed ID: 21444211
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients.
Aikawa NE; Trudes G; Campos LM; Pereira RM; Moraes JC; Ribeiro AC; Miraglia J; Timenetsky Mdo C; Bonfa E; Silva C
Lupus; 2013 Nov; 22(13):1394-8. PubMed ID: 24076765
[TBL] [Abstract][Full Text] [Related]
15. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
16. Effect of prior vaccination with a seasonal trivalent influenza vaccine on the antibody response to the influenza pandemic H1N1 2009 vaccine: a randomized controlled trial.
Uno S; Kimachi K; Kei J; Miyazaki K; Oohama A; Nishimura T; Ibaragi K; Odoh K; Kudo Y; Kino Y
Microbiol Immunol; 2011 Nov; 55(11):783-9. PubMed ID: 21895745
[TBL] [Abstract][Full Text] [Related]
17. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
19. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
20. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
Esposito S; Tagliaferri L; Daleno C; Valzano A; Picciolli I; Tel F; Prunotto G; Serra D; Galeone C; Plebani A; Principi N
Vaccine; 2011 Feb; 29(8):1677-82. PubMed ID: 21199699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
